top
person-image

Lupus alpha All Opportunities Fund C

WKN : A0M99W | ISIN: LU0329425713

Lupus alpha All Opportunities Fund C

The Lupus alpha All Opportunities Fund follows a stock strategy focused on small- and mid-cap companies, utilizing a broad set of opportunities based on fundamental research. It leverages the diverse performance drivers of the small- and mid-cap universe while simultaneously reducing fluctuation risks.

It is thus particularly suitable for investors who want to benefit from lucrative opportunities in European small- and mid-cap stocks but do not want to be fully exposed to the overall stock market risk.

Highlights

  • European small- and mid-cap focused stock strategy

  • Significantly lower risk than “long only”-strategies due to hedging component

  • Participation in information inefficiencies and emerging market opportunities.

  • Utilization of the excellent expertise of one of the largest small- and mid-cap teams in Germany
Team expertise

Lupus alpha All Opportunities Fund's low-beta strategy makes use of Lupus alpha's highly specialised expertise in the small- and mid-cap segment:

FOCUSED TEAM

... and one of the largest small & mid cap teams in Europe

LONGSTANDING EXPERIENCE

... in the team and an excellent track record since 2001

DETAILED COMPANY KNOWLEDGE

... based on around 1,500 direct and personal company contacts per year

LARGE INVESTMENT UNIVERSE

... with around 2,000 individual stocks – ideal for stock picking to achieve alpha

Investment concept

Small- and mid-cap strategy with lower volatility

The Lupus alpha All Opportunities Fund primarily invests in the asset class of European small and mid caps. It benefits from the performance drivers of the small- and mid-cap universe: diversity, structural growth, and above-average participation in technological advancement, while simultaneously reducing fluctuation risks.

The strategy is based on four pillars, which can be summarized in long and short positions as well as special situations and a hedging component. The focus of stock selection is on high-quality companies that are market leaders, exhibit pricing power, and have strong management. In addition, the fund opportunistically exploits special situations such as M&A transactions or IPOs to benefit from the resulting market inefficiencies.

Within its investment universe of approximately 2,000 securities, the fund offers the opportunity to flexibly profit from trends in the stock market. Broad diversification, strict criteria in individual stock selection, and a stringent risk management process are integral parts of portfolio management to mitigate/monitor/reduce overall risk.

Additionally, stress tests are regularly conducted to complete risk monitoring for the long-short strategy.

Investment objective

The fund aims to outperform the European stock market on a risk-adjusted basis over the long term.

Our Portfolio managers

Experienced fund manager

Franz Führer is a fund manager with considerable experience in small and mid caps, and has been with Lupus alpha since 2001. Björn Wolf is also a fund manager with several years of experience in small and mid caps, and has been with Lupus alpha since 2019.

Franz Führer, Portfolio Manager bei Lupus alpha
Franz Führer
Partner, Portfolio Management Small & Mid Caps Europe
Björn Wolf, Portfolio Manager bei Lupus alpha
Björn Wolf
CESGA, Portfolio Management & Research Small & Mid Caps Europe
Fund data
Performance since 01.07.2014: +1.75 %
As of: 31.07.2014

Performance (gross in EUR)¹:

202220232024
Jan -1.05 %2.62 %-4.34 %
Feb -1.84 %0.72 %-1.81 %
Mar 0.34 %-2.85 %2.31 %
Apr -0.40 %-0.10 %0.71 %
May 3.49 %0.68 %0.88 %
Jun -5.69 %1.00 %-1.60 %
Jul -0.53 %3.87 %0.62 %
Aug -0.43 %0.43 %-1.07 %
Sep -4.47 %-0.36 %-0.12 %
Oct 2.86 %-3.60 %-3.35 %
Nov 0.67 %2.28 %n.a.
Dec 1.23 %5.88 %n.a.
Year -6.04 %10.69 %n.a.

fromtoLupus alpha All Opportunities Fund C
1 month 30.09.202431.10.2024-3.35 %
90 days 02.08.202431.10.2024-3.84 %
1 year 31.10.202331.10.2024-0.04 %
3 years 29.10.202131.10.2024-7.75 %
5 years 31.10.201931.10.202416.53 %
this year 29.12.202331.10.2024-7.69 %
since inception 21.01.200831.10.2024153.08 %
since inception p.a. 21.01.200831.10.20245.69 %

12-month-timeframe (gross)Lupus alpha All Opportunities Fund C
31.10.2023 - 31.10.2024-0.04 %
31.10.2022 - 31.10.20234.16 %
31.10.2021 - 31.10.2022-11.40 %
31.10.2020 - 31.10.202134.73 %
31.10.2019 - 31.10.2020-5.38 %
31.10.2018 - 31.10.2019-5.46 %
31.10.2017 - 31.10.20181.39 %
31.10.2016 - 31.10.201718.27 %
31.10.2015 - 31.10.2016-0.65 %
31.10.2014 - 31.10.201510.71 %

Key Statistics³:

as ofLupus alpha All Opportunities Fund C
Volatility p.a. 31.10.20247.94 %
Maximum Draw Down 90 Days 31.10.2024-19.07 %
VaR 95 - 10 31.10.2024-1.81 %
VaR 99 - 10 31.10.2024-2.56 %
Sharpe Ratio 31.10.20240.65
Average Equity Exposure (beta adjusted) 31.10.202432.33 %
Maximum Draw Down 31.10.2024-23.21 %

Correlations¹° as of 31/10/2024

Stoxx® Europe TMI Small 0.60
REXP -0.14

Sector allocation as of 31/10/2024

Country allocation as of 31/10/2024

Chances

  • You benefit from the long-term experience of the largest small- and mid -cap teams.
  • Excellent and long-standing historical performance.
  • Promising upside potential of European small- and mid-cap stocks.
  • Flexible exploitation of various trends and opportunies in the stock markets.
  • Participation in fundamental and technical events of individual stocks.
  • You can benefit from the deep network that our fund managers foster with small- and mid-cap companies of our investment universe.

 

Risks

  • Concentration risk: If investment is concentrated on particular assets or markets, the fund becomes particularly heavily dependent on the performance of these assets or markets.
  • Risks connected with derivates transactions: Changes in the price of the underlying asset can devalue a derivative. If derivatives are used as part of the investment strategy, the Derivatives might have leverage effects that impact the fund more strongly than the underlying asset. When selling derivates, there is the risk that the fund will suffer an indefinite loss amount.
  • Operational risk: The fund can become the victim of fraud, criminal acts pr errors by company employees or external third parties. Finally, managment of the fund can be negatively impacted by external events such as fires, natural disasters or similar.
  • Liquidity risk: If securities are trades in a relatively narrow market segment, it can be difficult to resell them in situations where there is insufficient liquidity. 
  • Interest-rate risk: Changes in market interest rates can affect the price of fixed-income securities. These fluctuations vary, however, depending on the term of the fixed-income securities.
  • Risk of price changes: Experience shows that equities are subject to sharp price fluctuations and thus the risk of price declines. These fluctuations are particularly impacted by the earnings development of the issuing company as well as sector trends and overall economic development. 
  • Market risk: The performance of financial products depends on the development of the capital markets.
  • Currency risk: Changes in exchange rates can affect the price of fund shares. 

Current fund data as of 11/21/2024

Lupus alpha All Opportunities Fund C
WKN : A0M99W | ISIN: LU0329425713
Currency
EUR
Issue price
130,41
Redemption price
124,20
Fund volume
66,32 Mio.
Launch date
21. janvier 2008
Minimum investment amount
500.000
Distribution frequency
distribution
Portfolio managers
Franz Führer, Björn Wolf
Performance fee
20 %
Administration fee
1,0 %
Hurdle Rate
2 % p.a.
Subscription fee
up to 5 %
High-Watermark
yes
Benchmark
€STR (ESTRON Index)
Unit price determined
daily
Fund price publication
www.fundinfo.com

Current fund data as of 11/21/2024

Lupus alpha All Opportunities Fund A
WKN : A0Q7VN | ISIN: LU0381944619
Currency
EUR
Issue price
110,43
Redemption price
105,17
Fund volume
66,32 Mio.
Launch date
31. mai 2019
Minimum investment amount
none
Distribution frequency
distribution
Portfolio managers
Franz Führer, Björn Wolf
Performance fee
20 %
Administration fee
1,8 %
Hurdle Rate
2 % p.a.
Subscription fee
up to 5 %
High-Watermark
yes
Benchmark
€STR (ESTRON Index)
Unit price determined
daily
Fund price publication
www.fundinfo.com

This fund information is provided for general information purposes. This information is not designed to replace the investor‘s own market research nor any other legal, tax or financial information or advice. The information presented does not constitute an invitation to buy or sell or investment advice. It does not contain all key information required to make important economic decisions and may differ from information and estimates provided by other sources or market participants. We accept no liability for the accuracy, completeness or topicality of this information. All statements are based on our assessment of the present legal and tax situation. All opinions reflect the current views of the portfolio manager and can be changed without prior notice. Full details of our funds and their licenses of distribution can be found in the relevant current sales prospectus and, where appropriate, Key Investor Information Document , supplemented by the latest audited annual report and/or half-year report. The relevant sales prospectus and Key Investor Information Documents prepared in German are the sole legally-binding basis for the purchase of funds managed by Lupus alpha Investment GmbH. You can obtain these documents free of charge from Lupus alpha Investment GmbH, P.O. Box 1112 62, 60047 Frankfurt am Main, Germany, upon request by calling +49 69 365058-7000, by e-mailing service@lupusalpha.de or via our website www.lupusalpha.de. If funds are licensed for distribution in Austria the respective sales prospectus, Key Investor Information Document and the latest audited annual report or half-year report are available from the Austrian paying and information agent UniCredit Bank Austria AG based in Rothschildplatz 1, 1020 Vienna, Austria. Fund units can be obtained from banks, savings banks and independent financial advisors.

Neither this fund information nor its contents or a copy thereof may be amended, reproduced or transmitted to third parties in any way without the prior written consent of Lupus alpha Investment GmbH. By accepting this document, you declare your consent to comply with the aforementioned provisions. Subject to change without notice.

Lupus alpha Investment GmbH
Speicherstraße 49–51
D-60327 Frankfurt am Main

  1. Source: Lupus alpha; gross performance (BVI method): The gross performance considers all costs incurred at Fund level (e. g. management fee) and assumes reinvestment of any distributions. Costs incurred at customer level such as sales charge and securities account costs are not included. Unless otherwise specified, all indicated performance data show the gross performance. Please note: Past per-formance is not a reliable indicator for future performance.
  2. Source: Lupus alpha; gross performance (BVI method): The gross performance considers all costs incurred at Fund level (e. g. management fee) and assumes reinvestment of any distributions. Costs incurred at customer level such as sales charge and securities account costs are not included. Unless otherwise specified, all indicated performance data show the gross performance. Please note: Past per-formance is not a reliable indicator for future performance.
  3. Volatility: Volatility is the range of variation of a security price or index around its mean value over a fixed period of time. A security is regarded as volatile if its price fluctuates heavily. Maximum loss 90 days: The maximum loss specifies an investor's potential loss if he had bought during the past 90 days at the highest price and sold at the lowest price. VaR 95 – 10: Value at Risk defines the level of loss which will not be exceeded within 10 days with a probability of 95%. VaR 99 – 10: Value at Risk defines the level of loss which will not be exceeded within 10 days with a probability of 99%. Sharpe Ratio: Sharpe Ratio is the excess return (Fund performance less money market rate) in relation to the range of variation (volatility) and shows the yield of the Fund per risk unit. The higher the Sharpe Ratio, the more yield has been generated in relation to the risk incurred. Maximum drawdown: The maximum drawdown is the largest percentage drop in value in a given period of time. It measures the amount the fund falls from its highest point to its lowest point in the selected timeframe.
  4. The sales charge is the difference between the sales price and the unit value. The sales charge varies depending on the type of the Fund and the distribution channel and usually covers the advisory and distribution costs. The Distributor will demand the sales charge at its own discretion.
  5. The management fee is the fee for managing the Fund and taken from the Fund's assets; it is paid to Lupus alpha for the management and administration of the Fund.
  6. The performance fee is a performance-related remuneration depending on the performance or the achievement of specific objectives such as a better performance compared to a benchmark. The costs may also be levied if a pre-defined minimum performance has been achieved.
  7. The hurdle rate means a specific minimum interest and/or profit threshold a Fund has to achieve in order to allow the investment company to participate in the Fund's profit.
  8. Performance fees of investment companies are frequently bound by a high wa-termark - the all-time high of the Fund. This means that a commission entitlement arises only if that mark has been exceeded.
  9. Distributing Funds do not reinvest the generated income, they pay out the income to the investor.
  10. The correlation measures the strength of the statistical relationship between two variables. A positive correlation means "the more ... the more", a negative correlation means "the more ...the less". The value of correlation is in the range between -1 (completely opposed) and +1 (completely equal). Correlations are some kind of no-tice on but no evidence for causalities which mean proven cause-effect relation-ships.
  11. The pairs trade or pair trading is a market neutral trading strategy enabling traders to profit from virtually any market conditions: uptrend, downtrend, or sideways movement. This strategy is categorized as a statistical arbitrage and convergence trading strategy.
  12. Morningstar Rating™ Total: © (2019) Morningstar Inc. All Rights Reserved. The information contained herein: 1. is intended for Morningstar and/or its content providers. 2. may not be reproduced or distributed; and 3. their accuracy, completeness or timeliness is not guaranteed. Neither Morningstar nor their content providers are responsible for any damages or losses arising from the use of this information. Ratings related to the previous month.
Awards
Alternative Investment Award 2022
Alternative Investments Award 2022 by GELD-Magazins
Logo Awards FundAward 2022
€uro Fund Award 2022
Awards Alternative Investment Awards 2021
Alternative Investments Award 2021 from GELD-Magazin
Awards FundAward 2021
€uro Fund Award 2021
Awards Alternative Investment Award 2020
Alternative Investments Award 2020 from GELD-Magazin
Logo Awards FundAward 2020, Lupus alpha
€uro Fund Award 2020
Awards Alternative Investment Award 2018
Alternative Investments Award 2019
Logo Awards FundAward 2019
€uro Fund Award 2019
Awards Alternative Investment Award 2018
Alternative Investments Award 2018
Logo Awards FundAward 2018, Lupus alpha
€uro Fund Award 2018
Logo Awards Alternative Investment Awards Platz 2
Alternative Investments Award 2017
Awards FundAward 2017, Lupus alpha
€uro Fund Award 2017
Logo Awards FundAward 2016, Lupus alpha
€uro Fund Award 2016
Funds overview
WKN: A0Q7VN | ISIN: LU0381944619
105.17 EUR
NAV from 11/21/2024
+0.33 %
T-1
-8.43 %
YTD
+9.66 %
5 Years
More information
WKN: A0M99W | ISIN: LU0329425713
124.2 EUR
NAV from 11/21/2024
+0.34 %
T-1
-7.77 %
YTD
+16.66 %
5 Years
More information
WKN: A1JDV6 | ISIN: DE000A1JDV61
226.39 EUR
NAV from 11/21/2024
+0.04 %
T-1
-3.33 %
YTD
+4.55 %
5 Years
More information
WKN: A1XDX7 | ISIN: DE000A1XDX79
127.97 EUR
NAV from 11/21/2024
+0.04 %
T-1
-3.93 %
YTD
+0.95 %
5 Years
More information
WKN: A2JB8X | ISIN: LU1891775774
139.52 EUR
NAV from 11/21/2024
+0.19 %
T-1
-3.81 %
YTD
+27.40 %
5 Years
More information
WKN: A2JB8Y | ISIN: LU1891775857
148.06 EUR
NAV from 11/21/2024
+0.20 %
T-1
-3.03 %
YTD
+32.92 %
5 Years
More information
WKN: 974564 | ISIN: LU0129233093
414.83 EUR
NAV from 11/21/2024
-0.07 %
T-1
-9.23 %
YTD
+14.65 %
5 Years
More information
WKN: 940640 | ISIN: LU0129233507
474.22 EUR
NAV from 11/21/2024
-0.07 %
T-1
-8.82 %
YTD
+17.95 %
5 Years
More information
270.89 EUR
NAV from 11/21/2024
+0.07 %
T-1
-9.47 %
YTD
+24.87 %
5 Years
More information
312.16 EUR
NAV from 11/21/2024
+0.08 %
T-1
-9.07 %
YTD
+28.77 %
5 Years
More information
190.65 EUR
NAV from 11/21/2024
+0.31 %
T-1
-1.49 %
YTD
+17.83 %
5 Years
More information
96.54 EUR
NAV from 11/21/2024
+0.30 %
T-1
-1.97 %
YTD
n.a.
5 Years
More information
WKN: A2H7DG | ISIN: LU1717012527
99.58 EUR
NAV from 11/21/2024
+0.25 %
T-1
+5.68 %
YTD
+2.99 %
5 Years
More information
WKN: A2DJR6 | ISIN: LU1535992389
110.65 EUR
NAV from 11/21/2024
+0.25 %
T-1
+6.25 %
YTD
+6.12 %
5 Years
More information
WKN: A2DTNQ | ISIN: DE000A2DTNQ7
97.83 EUR
NAV from 11/21/2024
+0.45 %
T-1
+2.09 %
YTD
+6.58 %
5 Years
More information
WKN: A2DTNW | ISIN: DE000A2DTNW5
85.73 EUR
NAV from 11/21/2024
+0.46 %
T-1
+1.50 %
YTD
n.a.
5 Years
More information
WKN: A1XDX3 | ISIN: DE000A1XDX38
108.86 EUR
NAV from 11/21/2024
+0.01 %
T-1
+8.05 %
YTD
+19.87 %
5 Years
More information
WKN: A1J9DU | ISIN: DE000A1J9DU7
134.27 EUR
NAV from 11/21/2024
+0.20 %
T-1
+6.18 %
YTD
+18.77 %
5 Years
More information
WKN: A0MS72 | ISIN: DE000A0MS726
141.57 EUR
NAV from 11/21/2024
+0.43 %
T-1
+12.82 %
YTD
+24.93 %
5 Years
More information
WKN: A0MS73 | ISIN: DE000A0MS734
66.53 EUR
NAV from 11/21/2024
+0.42 %
T-1
+12.27 %
YTD
+21.09 %
5 Years
More information


Actuellement, il n'y a malheureusement pas encore de fonds disponibles ici.